How can OSSURE™ LOEP help patients?

The information is for healthcare professionals only.

See how AgNovos is developing treatments to address local bone loss

External Links

Treatment of bone loss in proximal femurs of postmenopausal osteoporotic women with AGN1 local osteo-enhancement procedure (LOEP) increases hip bone mineral density and hip strength: a long-term prospective cohort study:

In Vitro Injection of Osteoporotic Cadaveric Femurs with a Triphasic Calcium-Based Implant Confers Immediate Biomechanical Integrity:

AgNovos Healthcare Receives Breakthrough Designation for Spine Device:

Local osteo enhancement of osteoporotic vertebra with a triphasic bone implant material increases strength—a biomechanical study:

European guidance for the diagnosis and management of osteoporosis in postmenopausal women:

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures:

$Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures:$

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture:

$Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture:$

Prophylactic augmentation of the osteoporotic proximal femur—mission impossible?:

About AgNovos

AgNovos Bioscience was founded by Dr. James Howe in 2012. Dr. Howe is a bone health scientist, researcher and orthopedic surgeon who practiced clinically for more than 30 years. The Company is focused on developing and commercializing treatments intended to help save and enhance the lives of millions of women and men. We are inspired and informed by our founder's decades of clinical experience and share his dedication to helping patients maintain their independence and quality of life through the development of treatments that enhance bone quality and strength. Whether people are affected by bone disease, joint disorders or trauma, we are committed to helping physicians address well-known unmet medical needs with truly breakthrough treatment solutions.

Contact: Medicalaffairs@AgNovos.com